ProKidney Corp (PROK)
1.86
-0.18
(-8.82%)
USD |
NASDAQ |
Sep 27, 16:00
1.86
0.00 (0.00%)
After-Hours: 20:00
ProKidney Enterprise Value: 1.248B for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 1.248B |
| September 26, 2024 | 1.270B |
| September 25, 2024 | 1.273B |
| September 24, 2024 | 1.300B |
| September 23, 2024 | 1.290B |
| September 20, 2024 | 1.323B |
| September 19, 2024 | 1.314B |
| September 18, 2024 | 1.314B |
| September 17, 2024 | 1.314B |
| September 16, 2024 | 1.308B |
| September 13, 2024 | 1.314B |
| September 12, 2024 | 1.313B |
| September 11, 2024 | 1.316B |
| September 10, 2024 | 1.317B |
| September 09, 2024 | 1.314B |
| September 06, 2024 | 1.307B |
| September 05, 2024 | 1.312B |
| September 04, 2024 | 1.288B |
| September 03, 2024 | 1.316B |
| August 30, 2024 | 1.316B |
| August 29, 2024 | 1.313B |
| August 28, 2024 | 1.292B |
| August 27, 2024 | 1.292B |
| August 26, 2024 | 1.314B |
| August 23, 2024 | 1.314B |
| Date | Value |
|---|---|
| August 22, 2024 | 1.288B |
| August 21, 2024 | 1.314B |
| August 20, 2024 | 1.308B |
| August 19, 2024 | 1.316B |
| August 16, 2024 | 1.316B |
| August 15, 2024 | 1.314B |
| August 14, 2024 | 1.301B |
| August 13, 2024 | 1.299B |
| August 12, 2024 | 1.275B |
| August 09, 2024 | 1.288B |
| August 08, 2024 | 1.276B |
| August 07, 2024 | 1.244B |
| August 06, 2024 | 1.245B |
| August 05, 2024 | 1.240B |
| August 02, 2024 | 1.271B |
| August 01, 2024 | 1.288B |
| July 31, 2024 | 1.308B |
| July 30, 2024 | 1.293B |
| July 29, 2024 | 1.309B |
| July 26, 2024 | 1.322B |
| July 25, 2024 | 1.315B |
| July 24, 2024 | 1.278B |
| July 23, 2024 | 1.308B |
| July 22, 2024 | 1.283B |
| July 19, 2024 | 1.279B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
419.28M
Minimum
Aug 19 2022
2.419B
Maximum
Apr 18 2023
1.489B
Average
1.363B
Median
Enterprise Value Benchmarks
| EyePoint Pharmaceuticals Inc | 146.83M |
| Cassava Sciences Inc | 1.159B |
| Capricor Therapeutics Inc | 294.30M |
| Adverum Biotechnologies Inc | -29.47M |
| Regenxbio Inc | 243.41M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.51M |
| Total Expenses (Quarterly) | 43.06M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -31.72% |